Elyce Ozols

2.1k total citations
23 papers, 1.7k citations indexed

About

Elyce Ozols is a scholar working on Nephrology, Molecular Biology and Immunology. According to data from OpenAlex, Elyce Ozols has authored 23 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 6 papers in Molecular Biology and 5 papers in Immunology. Recurrent topics in Elyce Ozols's work include Chronic Kidney Disease and Diabetes (6 papers), Acute Kidney Injury Research (6 papers) and Advanced Glycation End Products research (4 papers). Elyce Ozols is often cited by papers focused on Chronic Kidney Disease and Diabetes (6 papers), Acute Kidney Injury Research (6 papers) and Advanced Glycation End Products research (4 papers). Elyce Ozols collaborates with scholars based in Australia, United States and China. Elyce Ozols's co-authors include David J. Nikolic‐Paterson, Greg H. Tesch, Robert C. Atkins, R. C. Atkins, Y. Frank, Barrett J. Rollins, Andy K. H. Lim, Michael Schneider, Min Xie and Richard A. Flavell and has published in prestigious journals such as International Journal of Molecular Sciences, Kidney International and Journal of the American Society of Nephrology.

In The Last Decade

Elyce Ozols

21 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elyce Ozols Australia 13 744 534 436 392 256 23 1.7k
Hitomi Usui Japan 13 659 0.9× 444 0.8× 200 0.5× 293 0.7× 369 1.4× 14 1.6k
Usha Panchapakesan Australia 22 585 0.8× 593 1.1× 300 0.7× 321 0.8× 681 2.7× 32 1.8k
Xuejing Zhu China 20 478 0.6× 701 1.3× 200 0.5× 197 0.5× 144 0.6× 34 1.5k
Alejandra Droguett Chile 19 596 0.8× 578 1.1× 229 0.5× 162 0.4× 178 0.7× 27 1.5k
Laure Hélène Noël France 7 894 1.2× 333 0.6× 224 0.5× 143 0.4× 288 1.1× 8 1.6k
Daisuke Ogawa Japan 22 605 0.8× 793 1.5× 195 0.4× 259 0.7× 816 3.2× 51 2.2k
Shuguang Yuan China 19 507 0.7× 672 1.3× 295 0.7× 150 0.4× 115 0.4× 43 1.4k
Keiichiro Matoba Japan 18 385 0.5× 480 0.9× 134 0.3× 154 0.4× 337 1.3× 41 1.2k
Qiuling Fan China 21 376 0.5× 622 1.2× 142 0.3× 189 0.5× 177 0.7× 70 1.3k
Joan C. Krepinsky Canada 28 543 0.7× 894 1.7× 142 0.3× 122 0.3× 205 0.8× 68 1.9k

Countries citing papers authored by Elyce Ozols

Since Specialization
Citations

This map shows the geographic impact of Elyce Ozols's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elyce Ozols with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elyce Ozols more than expected).

Fields of papers citing papers by Elyce Ozols

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elyce Ozols. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elyce Ozols. The network helps show where Elyce Ozols may publish in the future.

Co-authorship network of co-authors of Elyce Ozols

This figure shows the co-authorship network connecting the top 25 collaborators of Elyce Ozols. A scholar is included among the top collaborators of Elyce Ozols based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elyce Ozols. Elyce Ozols is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Tesch, Greg H., Elyce Ozols, James P. Morgan, Morag J. Young, & David J. Nikolic‐Paterson. (2025). Deficiency of mineralocorticoid receptor signalling in myeloid cells protects cardiac and kidney function in hypertensive diabetic mice. Clinical Science. 139(24). 1675–1689.
3.
Tesch, Greg H., Y. Frank, Elyce Ozols, & David J. Nikolic‐Paterson. (2024). Intervention treatment reducing cellular senescence inhibits tubulointerstitial fibrosis in diabetic mice following acute kidney injury. Clinical Science. 138(5). 309–326. 9 indexed citations
4.
Zhu, Bao‐Ping, Elyce Ozols, Haitao Bai, et al.. (2024). A gradient model of renal ischemia reperfusion injury to investigate renal interstitial fibrosis. International Journal of Immunopathology and Pharmacology. 38. 1210508522–1210508522. 1 indexed citations
5.
Tian, Lifang, Greg H. Tesch, Elyce Ozols, et al.. (2021). Mice with Established Diabetes Show Increased Susceptibility to Renal Ischemia/Reperfusion Injury. American Journal Of Pathology. 192(3). 441–453. 5 indexed citations
6.
Ozols, Elyce, William R. Mulley, Roger J. Davis, et al.. (2021). JUN Amino-Terminal Kinase 1 Signaling in the Proximal Tubule Causes Cell Death and Acute Renal Failure in Rat and Mouse Models of Renal Ischemia/Reperfusion Injury. American Journal Of Pathology. 191(5). 817–828. 12 indexed citations
7.
Yang, Fan, Elyce Ozols, Y. Frank, et al.. (2021). c-Jun Amino Terminal Kinase Signaling Promotes Aristolochic Acid-Induced Acute Kidney Injury. Frontiers in Physiology. 12. 599114–599114. 11 indexed citations
8.
Ozols, Elyce, et al.. (2021). Cyclophilin D Promotes Acute, but Not Chronic, Kidney Injury in a Mouse Model of Aristolochic Acid Toxicity. Toxins. 13(10). 700–700. 5 indexed citations
9.
Ozols, Elyce, John Kanellis, Shawn S. Badal, et al.. (2020). Cyclophilin Inhibition Protects Against Experimental Acute Kidney Injury and Renal Interstitial Fibrosis. International Journal of Molecular Sciences. 22(1). 271–271. 16 indexed citations
10.
Ozols, Elyce, et al.. (2020). Cyclophilin A Promotes Inflammation in Acute Kidney Injury but Not in Renal Fibrosis. International Journal of Molecular Sciences. 21(10). 3667–3667. 16 indexed citations
11.
Ozols, Elyce, et al.. (2017). Cyclophilin D promotes tubular cell damage and the development of interstitial fibrosis in the obstructed kidney. Clinical and Experimental Pharmacology and Physiology. 45(3). 250–260. 21 indexed citations
12.
Huang, Louis, David J. Nikolic‐Paterson, Yingjie Han, et al.. (2014). Myeloid Mineralocorticoid Receptor Activation Contributes to Progressive Kidney Disease. Journal of the American Society of Nephrology. 25(10). 2231–2240. 59 indexed citations
13.
Frank, Y., et al.. (2012). Macrophage infiltration and renal damage are independent of matrix metalloproteinase 12 in the obstructed kidney. Nephrology. 17(4). 322–329. 26 indexed citations
14.
Lim, Andy K. H., Y. Frank, David J. Nikolic‐Paterson, et al.. (2011). Evaluation of JNK Blockade as an Early Intervention Treatment for Type 1 Diabetic Nephropathy in Hypertensive Rats. American Journal of Nephrology. 34(4). 337–346. 32 indexed citations
15.
Frank, Y., Greg H. Tesch, Elyce Ozols, et al.. (2011). TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney. American Journal of Physiology-Renal Physiology. 300(6). F1410–F1421. 94 indexed citations
16.
Lim, Andy K. H., David J. Nikolic‐Paterson, Elyce Ozols, et al.. (2008). Role of MKK3–p38 MAPK signalling in the development of type 2 diabetes and renal injury in obese db/db mice. Diabetologia. 52(2). 347–358. 103 indexed citations
17.
18.
Nikolic‐Paterson, David J., et al.. (2005). Intercellular Adhesion Molecule-1 Deficiency Is Protective against Nephropathy in Type 2 Diabetic db/db Mice. Journal of the American Society of Nephrology. 16(6). 1711–1722. 249 indexed citations
19.
Nikolic‐Paterson, David J., et al.. (2005). Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. Kidney International. 69(1). 73–80. 378 indexed citations
20.
Ozols, Elyce, et al.. (2003). Macrophages in mouse type 2 diabetic nephropathy: Correlation with diabetic state and progressive renal injury. Kidney International. 65(1). 116–128. 469 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hitomi Usui Breakdown of academic impact, for papers by Usha Panchapakesan Breakdown of academic impact, for papers by Xuejing Zhu Breakdown of academic impact, for papers by Alejandra Droguett Breakdown of academic impact, for papers by Laure Hélène Noël Breakdown of academic impact, for papers by Daisuke Ogawa Breakdown of academic impact, for papers by Shuguang Yuan Breakdown of academic impact, for papers by Keiichiro Matoba Breakdown of academic impact, for papers by Qiuling Fan Breakdown of academic impact, for papers by Joan C. Krepinsky
Rankless by CCL
2026